WeVote

Bill

Bill

SB 166

AN ACT RELATING TO BUSINESSES AND PROFESSIONS -- PHARMACIES

2025 Regular Session Introduced by Bob Britto and 8 co-sponsors

Rhode Island Governor signed SB 166, a pharmacy regulation bill that passed both chambers after substitute amendments, effective July 2025.

07/02/2025 Signed by Governor
0
WeVote Research Nonpartisan
Bill Summary · SB 166

Legislative bill overview

SB 166 is a Rhode Island law signed by the Governor in July 2025 that modifies regulations governing pharmacy operations and professional practices. The bill underwent amendment during the legislative process, with a substitute version (Sub B) ultimately passing both chambers before gubernatorial approval.

Why is this important

Pharmacy regulations directly affect medication access, pricing, and patient safety for Rhode Island residents. Changes to pharmacy licensing, operational requirements, or professional standards can influence healthcare costs, service availability, and consumer protections across the state.

Potential points of contention

  • Scope of changes unclear — Without the bill's specific language, key areas of pharmacy regulation potentially affected (licensing requirements, scope of practice, insurance reimbursement, etc.) cannot be identified
  • Amendment significance — The passage of "Sub B" indicates substantial revisions from the original proposal, suggesting earlier versions faced legislative resistance or policy disagreements
  • Stakeholder impact — Depending on provisions, the bill may affect independent pharmacists, chains, insurers, and patients differently, potentially creating winners and losers in the healthcare market

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.